Lakefront Biotherapeutics NV - Ordinary shares, no par value (GLPG)

CUSIP: 36315X101

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / Ordinary shares, no par value
Shares outstanding
66,186,595
Total 13F shares
8,967,419
Share change
-971,953
Total reported value
$894,285,000
Put/Call ratio
161%
Price per share
$99.76
Number of holders
81
Value change
-$95,785,246
Number of buys
36
Number of sells
33

Security key

36315X101

Report period

Q1 2018

Institutions

81

Top holders

10

Top shareholders of GLPG - Lakefront Biotherapeutics NV - Ordinary shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
3.8%
2,510,992
$235,431,000 31 Dec 2017
13F
SANDS CAPITAL MANAGEMENT, LLC
13F
Company
3%
1,998,311
$187,362,000 31 Dec 2017
13F
FEDERATED HERMES, INC.
13F
Company
2%
1,350,534
$126,626,000 31 Dec 2017
13F
ORBIMED ADVISORS LLC
13F
Company
0.74%
486,990
$45,660,000 31 Dec 2017
13F
BlackRock Finance, Inc.
13F
Company
0.52%
346,802
$32,516,000 31 Dec 2017
13F
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
0.44%
290,000
$27,190,000 31 Dec 2017
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.41%
268,326
$25,158,000 31 Dec 2017
13F
BAKER BROS. ADVISORS LP
13F
Company
0.39%
259,894
$24,368,000 31 Dec 2017
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.36%
235,200
$22,052,000 31 Dec 2017
13F
PERCEPTIVE ADVISORS LLC
13F
Company
0.31%
206,305
$19,343,000 31 Dec 2017
13F
Rock Springs Capital Management LP
13F
Company
0.28%
185,000
$17,346,000 31 Dec 2017
13F
JANE STREET GROUP, LLC
13F
Company
0.21%
137,212
$12,865,000 31 Dec 2017
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
0.2%
130,000
$12,189,000 31 Dec 2017
13F
PEREGRINE CAPITAL MANAGEMENT LLC
13F
Company
0.18%
117,211
$10,990,000 31 Dec 2017
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.18%
116,616
$10,934,000 31 Dec 2017
13F
EcoR1 Capital, LLC
13F
Company
0.17%
110,384
$10,350,000 31 Dec 2017
13F
CREDIT SUISSE AG/
13F
Company
0.14%
95,195
$8,926,000 31 Dec 2017
13F
MORGAN STANLEY
13F
Company
0.13%
84,133
$7,888,000 31 Dec 2017
13F
DEUTSCHE BANK AG\
13F
Company
0.11%
72,120
$6,760,000 31 Dec 2017
13F
Alberta Investment Management Corp
13F
Company
0.11%
70,000
$6,563,000 31 Dec 2017
13F
NORGES BANK
13F
Company
0.11%
70,000
$6,563,000 31 Dec 2017
13F
CLOUGH CAPITAL PARTNERS L P
13F
Company
0.1%
66,453
$6,231,000 31 Dec 2017
13F
Dorsey Wright & Associates
13F
Company
0.1%
66,187
$6,205,000 31 Dec 2017
13F
ALPS ADVISORS INC
13F
Company
0.09%
56,310
$5,280,000 31 Dec 2017
13F
Employees Retirement System of Texas
13F
Company
0.08%
54,000
$5,063,000 31 Dec 2017
13F
Tekla Capital Management LLC
13F
Company
0.08%
53,200
$4,988,000 31 Dec 2017
13F
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
0.08%
52,000
$4,876,000 31 Dec 2017
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.07%
45,404
$4,257,000 31 Dec 2017
13F
DAFNA Capital Management LLC
13F
Company
0.06%
39,609
$3,714,000 31 Dec 2017
13F
Bank of New York Mellon Corp
13F
Company
0.06%
39,445
$3,698,000 31 Dec 2017
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.06%
38,952
$3,652,000 31 Dec 2017
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.06%
38,050
$3,568,000 31 Dec 2017
13F
JPMORGAN CHASE & CO
13F
Company
0.04%
26,718
$2,505,000 31 Dec 2017
13F
FNY Partners Fund LP
13F
Company
0.03%
20,200
$1,893,000 31 Dec 2017
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.03%
18,837
$1,766,000 31 Dec 2017
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.03%
18,296
$1,715,000 31 Dec 2017
13F
Atika Capital Management LLC
13F
Company
0.02%
15,500
$1,453,000 31 Dec 2017
13F
P.A.W. CAPITAL CORP
13F
Company
0.02%
12,000
$1,125,000 31 Dec 2017
13F
Unterberg Capital LLC
13F
Company
0.02%
12,000
$1,125,000 31 Dec 2017
13F
Freedom Investment Management, Inc.
13F
Company
0.02%
11,343
$1,064,000 31 Dec 2017
13F
Jefferies Group LLC
13F
Company
0.02%
10,745
$1,007,000 31 Dec 2017
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.02%
10,302
$967,000 31 Dec 2017
13F
MACQUARIE GROUP LTD
13F
Company
0.01%
9,600
$900,000 31 Dec 2017
13F
Aperio Group, LLC
13F
Company
0.01%
7,603
$713,000 31 Dec 2017
13F
CASTLEARK MANAGEMENT LLC
13F
Company
0.01%
6,770
$635,000 31 Dec 2017
13F
WILLIAMS JONES & ASSOCIATES LLC
13F
Company
0.01%
6,645
$623,000 31 Dec 2017
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.01%
5,938
$556,000 31 Dec 2017
13F
ProShare Advisors LLC
13F
Company
0.01%
5,875
$551,000 31 Dec 2017
13F
BANK OF MONTREAL /CAN/
13F
Company
0.01%
5,205
$488,000 31 Dec 2017
13F
LANDSCAPE CAPITAL MANAGEMENT, L.L.C.
13F
Company
0.01%
4,141
$388,000 31 Dec 2017
13F

Institutional Holders of Lakefront Biotherapeutics NV - Ordinary shares, no par value (GLPG) as of Q1 2018

As of 31 Mar 2018, Lakefront Biotherapeutics NV - Ordinary shares, no par value (GLPG) was held by 81 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,967,419 shares. The largest 10 holders included SANDS CAPITAL MANAGEMENT, LLC, FMR LLC, FEDERATED INVESTORS INC /PA/, ORBIMED ADVISORS LLC, BlackRock Inc., FARALLON CAPITAL MANAGEMENT LLC, BAKER BROS. ADVISORS LP, WELLINGTON MANAGEMENT GROUP LLP, RENAISSANCE TECHNOLOGIES LLC, and PERCEPTIVE ADVISORS LLC. This page lists 81 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2018 vs Q4 2017 Across Filers

Q4 2017 holders
73
Q1 2018 holders
81
Holder diff
8
Investor Q4 2017 Shares Q1 2018 Shares Share Diff Share Chg % Q4 2017 Value $ Q1 2018 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .